menu

ReachMD

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

A Glimpse at Immunomodulators in MS

    Join us as Lawrence Sherman speaks with Dr. Mark Freedman on immunomodulators in multiple sclerosis and the need for patient-centric care. STATEME...

    Available credits: 0.25

    Released:

    Valid until:

    Take Post-Test

    If you’ve already completed the activity.

    • Overview

      Join us as Lawrence Sherman speaks with Dr. Mark Freedman on immunomodulators in multiple sclerosis and the need for patient-centric care.

      STATEMENT:

      As of August 2018, Cladribine was approved in Europe for the treatment of highly active relapsing multiple sclerosis (RMS). All studies presented in this education are still accurate. To learn more about this approval, click here.

    • Learning Objectives

      At the completion of this module, participants should be better able to:

      1. Discuss the history of immunomodulators in the treatment of relapsing-remitting multiple sclerosis (MS)
      2. Identify disease modifying therapies for MS in the periphery and in the CNS
      3. Discuss the need for an organized plan or algorithm for the treatment of MS in a patient-centered regimen of care
      4. Identify lifestyle and non-pharmacologic considerations in the treatment of the patient with MS
    • Accreditation and Credit Designation Statements

      The Omnia-Prova Education Collaborative, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

      The Omnia-Prova Education Collaborative, Inc. designates this enduring material for a maximum of .25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

      A statement of credit will be issued only upon receipt of a completed activity evaluation form and will be available for immediate download.

    • Target Audience

      This course is designed to meet the Continuing Medical Education needs of the practicing neurologist.

    • Commercial Support

      This activity is supported by an independent educational grant from Merck KGaA, Darmstadt, Germany.

      Original Release Date: 25 January 2017
      Expiration Date: 25 January 2018

    • Disclosure of Conflicts of Interest

      In accordance with the ACCME Standards for Commercial Support, The Omnia-Prova Education Collaborative (TOPEC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any commercial interest. TOPEC resolves all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all its educational programs.

      Faculty

      Mark S. Freedman, MSc, MD, FRCPC
      Professor of Neurology
      University of Ottawa
      Ottawa, Canada
      Financial Relationship Disclosure:
      Consulting Fees: Bayer, Biogen, EMD Serono, Inc., Genzyme, GSK, Novartis, Roche Diagnostics, Sanofi, and Teva Pharmaceutical 

      Reviewers/Planners/Authors

      • Ann Early has nothing to disclose.
      • Barry A. Fiedel, PhD has nothing to disclose.
      • Ashley Pluta has nothing to disclose.
      • Lawrence Sherman, FACEHP, CHCP has nothing to disclose.
    • Instructions

      Disclosure of Unlabeled Use
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Omnia-Prova Education Collaborative (TOPEC) does not recommend the use of any agent outside of the labeled indications.
      The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      Contact Information
      In case of technical needs, please contact: info@globalmultiplesclerosisacademy.org

    • Disclaimer

      All rights reserved. No part of this publication may be reproduced without written permission from the publisher.

      The material presented in this Global Multiple Sclerosis Academy continuing medical education activity does not necessarily reflect the views and opinions of Global Multiple Sclerosis Academy . NeitherGlobal Multiple Sclerosis Academy nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the US Food and Drug Administration. All readers and continuing education participants should verify all information before treating patients or utilizing any product.

    • System Requirements

      Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience."

    Facebook Comments

    LIVE ON REACHMD RADIOBack to live radio
    ReachMD Radio

    Loading...

    00:00
    00:00

      You must be in to display playlists.

      Get a Dose of ReachMD in Your Inbox
      and Practice Smarter Medicine

      Stay current with the best in medical education.